Evidence map›Paper›PMID 38655069›Full record

ArticleSurgery open science2024

Machine learning based predictive modeling of readmissions following extracorporeal membrane oxygenation hospitalizations.

Jeffrey Balian, Sara Sakowitz, Arjun Verma, Amulya Vadlakonda, Emma Cruz, Konmal Ali, Peyman Benharash

Open access · goldAbstract read
In one paragraph

Article in Surgery open science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jeffrey BalianCardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, CA, United States of America.
Sara SakowitzCardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, CA, United States of America.
Arjun VermaCardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, CA, United States of America.
Amulya VadlakondaCardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, CA, United States of America.
Emma CruzCardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, CA, United States of America.
Konmal AliCardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, CA, United States of America.
Peyman BenharashCardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, CA, United States of America.
University of California, Los Angeles · USCore Laboratories (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Despite increasing utilization and survival benefit over the last decade, extracorporeal membrane oxygenation (ECMO) remains resource-intensive with significant complications and rehospitalization risk. We thus utilized machine learning (ML) to develop prediction models for 90-day nonelective readmission following ECMO. Methods: All adult patients receiving ECMO who survived index hospitalization were tabulated from the 2016-2020 Nationwide Readmissions Database. Extreme Gradient Boosting (XGBoost) models were developed to identify features associated with readmission following ECMO. Area under the receiver operating characteristic (AUROC), mean Average Precision (mAP), and the Brier score were calculated to estimate model performance relative to logistic regression (LR). Shapley Additive Explanation summary (SHAP) plots evaluated the relative impact of each factor on the model. An additional sensitivity analysis solely included patient comorbidities and indication for ECMO as potential model covariates. Results: Of ∼22,947 patients, 4495 (19.6 %) were readmitted nonelectively within 90 days. The XGBoost model exhibited superior discrimination (AUROC 0.64 vs 0.49), classification accuracy (mAP 0.30 vs 0.20) and calibration (Brier score 0.154 vs 0.165, all P < 0.001) in predicting readmission compared to LR. SHAP plots identified duration of index hospitalization, undergoing heart/lung transplantation, and Medicare insurance to be associated with increased odds of readmission. Upon sub-analysis, XGBoost demonstrated superior disclination compared to LR (AUROC 0.61 vs 0.60, P < 0.05). Chronic liver disease and frailty were linked with increased odds of nonelective readmission. Conclusions: ML outperformed LR in predicting readmission following ECMO. Future work is needed to identify other factors linked with readmission and further optimize post-ECMO care among this cohort.

Indexed as

ECMOExtracorporeal membrane oxygenationHCUPMachine learningNational Readmissions DatabaseXGBoost

Identifiers

PMID38655069
PMCPMC11035075
OpenAlexW4394681120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.